Submitted:
31 July 2026
Posted:
03 August 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Ethical Approval
2.3. Study Setting and Recruitment
2.4. Eligibility Criteria
2.5. Data Collection
2.6. Materials
2.7. Data Analysis
3. Results
3.1. Participant Characteristics
3.2. Themes
3.2.1. Theme 1: Intention to repeat CDED & PEN
3.2.2. Theme 2: Barriers Against CDED & PEN Adherence
3.2.3. Theme 3: Facilitators of CDED & PEN adherence
3.2.4. Theme 4: Dual Factors Acting as Both Barriers and Facilitators to CDED & PEN Adherence
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| CD | Crohn’s Disease |
| CDED | Crohn’s Disease Exclusion Diet |
| EEN | Exclusive Enteral Nutrition |
| EN | Enteral Nutrition |
| IBD | Inflammatory Bowel Disease |
| GI | Gastrointestinal |
| PEN | Partial Enteral Nutrition |
References
- Baumgart, D.C.; Sandborn, W.J. Crohn's disease. The Lancet 2012, 380, 1590–1605. [Google Scholar] [CrossRef] [PubMed]
- Strongylou, D.E.; Svolos, V.; Vlachou, A.; Zoupa, E.; Vakouftsi, V.-R.; Ntanou, A.; Argyriou, K.; Kapsoritakis, A.; Bonoti, F.; Androutsos, O. Understanding the Tripartite Relationship Between Dietary Practices, Psychological Well-Being, and Disease Experience in Greek Patients with IBD: A Mixed-Methods Exploration. Nutrients 2026, 18, 1439. [Google Scholar] [CrossRef] [PubMed]
- Mak, J.W.Y.; Sun, Y.; Limsrivilai, J.; Abdullah, M.; Kaibullayeva, J.; Balderramo, D.; Vergara, B.I.; Paudel, M.S.; Banerjee, R.; Hilmi, I.; et al. Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21). BMC Med. Res. Methodol. 2023, 23, 129. [Google Scholar] [CrossRef] [PubMed]
- Ng, S.C.; Shi, H.Y.; Hamidi, N.; Underwood, F.E.; Tang, W.; Benchimol, E.I.; Panaccione, R.; Ghosh, S.; Wu, J.C.Y.; Chan, F.K.L.; et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. The Lancet 2017, 390, 2769–2778. [Google Scholar] [CrossRef] [PubMed]
- Mahid, S.S.; Minor, K.S.; Soto, R.E.; Hornung, C.A.; Galandiuk, S. Smoking and Inflammatory Bowel Disease: A Meta-analysis. Mayo Clin. Proc. 2006, 81, 1462–1471. [Google Scholar] [CrossRef] [PubMed]
- Parkes, G.C.; Whelan, K.; Lindsay, J.O. Smoking in inflammatory bowel disease: Impact on disease course and insights into the aetiology of its effect. J. Crohn's Colitis 2014, 8, 717–725. [Google Scholar] [CrossRef] [PubMed]
- Faye, A.S.; Allin, K.H.; Iversen, A.T.; Agrawal, M.; Faith, J.; Colombel, J.-F.; Jess, T. Antibiotic use as a risk factor for inflammatory bowel disease across the ages: a population-based cohort study. Gut 2023, 72, 663–670. [Google Scholar] [CrossRef] [PubMed]
- Gevers, D.; Kugathasan, S.; Denson, Lee A.; Vázquez-Baeza, Y.; Van Treuren, W.; Ren, B.; Schwager, E.; Knights, D.; Song, Se J.; Yassour, M.; et al. The Treatment-Naive Microbiome in New-Onset Crohn’s Disease. Cell Host Microbe 2014, 15, 382–392. [Google Scholar] [CrossRef] [PubMed]
- David, L.A.; Maurice, C.F.; Carmody, R.N.; Gootenberg, D.B.; Button, J.E.; Wolfe, B.E.; Ling, A.V.; Devlin, A.S.; Varma, Y.; Fischbach, M.A.; et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014, 505, 559–563. [Google Scholar] [CrossRef] [PubMed]
- Li, T.; Qiu, Y.; Yang, H.S.; Li, M.Y.; Zhuang, X.J.; Zhang, S.H.; Feng, R.; Chen, B.L.; He, Y.; Zeng, Z.R.; et al. Systematic review and meta-analysis: Association of a pre-illness Western dietary pattern with the risk of developing inflammatory bowel disease. J. Dig. Dis. 2020, 21, 362–371. [Google Scholar] [CrossRef] [PubMed]
- Milajerdi, A.; Ebrahimi-Daryani, N.; Dieleman, L.A.; Larijani, B.; Esmaillzadeh, A. Association of Dietary Fiber, Fruit, and Vegetable Consumption with Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Adv. Nutr. 2021, 12, 735–743. [Google Scholar] [CrossRef] [PubMed]
- The, L. Transformative advances in Crohn's disease management. The Lancet 2025, 406, 307. [Google Scholar] [CrossRef] [PubMed]
- Kumar, A.; Cole, A.; Segal, J.; Smith, P.; Limdi, J.K. A review of the therapeutic management of Crohn’s disease. Ther. Adv. Gastroenterol. 2022, 15, 17562848221078456. [Google Scholar] [CrossRef] [PubMed]
- Gerasimidis, K.; Godny, L.; Sigall-Boneh, R.; Svolos, V.; Wall, C.; Halmos, E. Current recommendations on the role of diet in the aetiology and management of IBD. Frontline Gastroenterol. 2022, 13, 160–167. [Google Scholar] [CrossRef] [PubMed]
- Gordon, H.; Minozzi, S.; Kopylov, U.; Verstockt, B.; Chaparro, M.; Buskens, C.; Warusavitarne, J.; Agrawal, M.; Allocca, M.; Atreya, R.; et al. ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment. J. Crohn's Colitis 2024, 18, 1531–1555. [Google Scholar] [CrossRef] [PubMed]
- Lee, H.H.; Yuan, Y.; Boland, B.S.; Chang, J.T.; Jairath, V.; Singh, S. Efficacy of Advanced Therapies in Achieving Remission by Disease Location in Crohn’s Disease: A Systematic Review and Meta-analysis. Clin. Gastroenterol. Hepatol. 2026, 24, 923–931. [Google Scholar] [CrossRef] [PubMed]
- Svolos, V.; Gordon, H.; Lomer, M.C.E.; Aloi, M.; Bancil, A.; Day, A.S.; Day, A.S.; Fitzpatrick, J.A.; Gerasimidis, K.; Gkikas, K.; et al. European Crohn’s and Colitis Organisation consensus on dietary management of inflammatory bowel disease. J. Crohn's Colitis 2025, 19. [Google Scholar] [CrossRef] [PubMed]
- Hansen, T.; Duerksen, D.R. Enteral Nutrition in the Management of Pediatric and Adult Crohn’s Disease. Nutrients 2018, 10, 537. [Google Scholar] [CrossRef] [PubMed]
- Donnellan, C.F.; Yann, L.H.; Lal, S. Nutritional management of Crohn’s disease. Ther. Adv. Gastroenterol. 2013, 6, 231–242. [Google Scholar] [CrossRef] [PubMed]
- Jatkowska, A.; White, B.; Gkikas, K.; Seenan, J.P.; MacDonald, J.; Gerasimidis, K. Partial Enteral Nutrition in the Management of Crohn’s Disease: A Systematic Review and Meta-Analysis. J. Crohn's Colitis 2025, 19. [Google Scholar] [CrossRef] [PubMed]
- Svolos, V.; Hansen, R.; Nichols, B.; Quince, C.; Ijaz, U.Z.; Papadopoulou, R.T.; Edwards, C.A.; Watson, D.; Alghamdi, A.; Brejnrod, A.; et al. Treatment of Active Crohn’s Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition. Gastroenterology 2019, 156, 1354–1367.e1356. [Google Scholar] [CrossRef] [PubMed]
- Halmos, E.P.; Godny, L.; Vanderstappen, J.; Sarbagili-Shabat, C.; Svolos, V. Role of diet in prevention versus treatment of Crohn’s disease and ulcerative colitis. Frontline Gastroenterol. 2024, 15, 247–257. [Google Scholar] [CrossRef] [PubMed]
- Sigall Boneh, R.; Westoby, C.; Oseran, I.; Sarbagili-Shabat, C.; Albenberg, L.G.; Lionetti, P.; Manuel Navas-López, V.; Martín-de-Carpi, J.; Yanai, H.; Maharshak, N.; et al. The Crohn’s Disease Exclusion Diet: A Comprehensive Review of Evidence, Implementation Strategies, Practical Guidance, and Future Directions. Inflamm. Bowel Dis. 2024, 30, 1888–1902. [Google Scholar] [CrossRef] [PubMed]
- Levine, A.; Wine, E.; Assa, A.; Sigall Boneh, R.; Shaoul, R.; Kori, M.; Cohen, S.; Peleg, S.; Shamaly, H.; On, A.; et al. Crohn’s Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial. Gastroenterology 2019, 157, 440–450.e448. [Google Scholar] [CrossRef] [PubMed]
- Fitzpatrick, J.A.; Melton, S.L.; Yao, C.K.; Gibson, P.R.; Halmos, E.P. Dietary management of adults with IBD — the emerging role of dietary therapy. Nat. Rev. Gastroenterol. Hepatol. 2022, 19, 652–669. [Google Scholar] [CrossRef] [PubMed]
- Czuber-Dochan, W.; Morgan, M.; Hughes, L.D.; Lomer, M.C.E.; Lindsay, J.O.; Whelan, K. Perceptions and psychosocial impact of food, nutrition, eating and drinking in people with inflammatory bowel disease: a qualitative investigation of food-related quality of life. J. Hum. Nutr. Diet. 2020, 33, 115–127. [Google Scholar] [CrossRef] [PubMed]
- Wijers, F.T.R.; van Zundert, S.M.C.; Verburgt, C.M.; van der Kruk, N.; Van Limbergen, J.E.; Wierdsma, N.J. Patient experiences with and adherence to Crohn’s disease exclusion diet in Dutch Crohn’s disease patients: a cohort study. Ther. Adv. Gastroenterol. 2025, 18, 17562848251323553. [Google Scholar] [CrossRef] [PubMed]
- Wang, J.; Zhang, Z.; Yang, M. Home-based enteral nutrition self-management challenges in young and middle-aged patients with Crohn’s disease: a qualitative study. BMJ Open 2025, 15, e096416. [Google Scholar] [CrossRef] [PubMed]
- Phillips, G. Patient and carer experience of blended diet via gastrostomy: a qualitative study. J. Hum. Nutr. Diet. 2019, 32, 391–399. [Google Scholar] [CrossRef] [PubMed]
- Sigall Boneh, R.; Navas-López, V.M.; Hussey, S.; Pujol-Muncunill, G.; Lawrence, S.; Rolandsdotter, H.; Otley, A.; Martín-de-Carpi, J.; Abramas, L.; Herrador-López, M.; et al. Modified Crohn’s Disease Exclusion Diet Maintains Remission in Pediatric Crohn’s Disease: Randomized Controlled Trial. Clin. Gastroenterol. Hepatol. 2025, 23, 2001–2011. [Google Scholar] [CrossRef] [PubMed]
- Szczubełek, M.; Pomorska, K.; Korólczyk-Kowalczyk, M.; Lewandowski, K.; Kaniewska, M.; Rydzewska, G. Effectiveness of Crohn’s Disease Exclusion Diet for Induction of Remission in Crohn’s Disease Adult Patients. Nutrients 2021, 13, 4112. [Google Scholar] [CrossRef] [PubMed]
- Svolos, V.; Gerasimidis, K.; Buchanan, E.; Curtis, L.; Garrick, V.; Hay, J.; Laird, S.; Munro, J.; Gaya, D.R.; Russell, R.K.; et al. Dietary treatment of Crohn’s disease: perceptions of families with children treated by exclusive enteral nutrition, a questionnaire survey. BMC Gastroenterol. 2017, 17, 14. [Google Scholar] [CrossRef] [PubMed]
- Wall, C.L.; Gearry, R.B.; Day, A.S. Polymeric formula is more palatable than elemental formula to adults with Crohn's disease. E-SPEN J. 2014, 9, e200–e203. [Google Scholar] [CrossRef]
- Rodrigues, A.F.; Johnson, T.; Davies, P.; Murphy, M.S. Does polymeric formula improve adherence to liquid diet therapy in children with active Crohn’s disease? Arch. Dis. Child. 2007, 92, 767–770. [Google Scholar] [CrossRef] [PubMed]
- Vivanco Karlsson, N.; Sigall-Boneh, R.; Mårild, K.; Hård Af Segerstad, E.M. Adapting the Crohn’s disease exclusion diet to a Nordic framework: a theoretical approach to cultural and nutritional customization. Front. Nutr. 2025, Volume 12 - 2025. [Google Scholar] [CrossRef] [PubMed]
- Meiners, F.; Ortega-Matienzo, A.; Fuellen, G.; Barrantes, I. Gut microbiome-mediated health effects of fiber and polyphenol-rich dietary interventions. Front. Nutr. 2025, Volume 12, 2025. [Google Scholar] [CrossRef] [PubMed]
- Russell, E.E.; Day, A.S.; Dimitroff, C.; Trakman, G.L.; Silva, H.; Bryant, R.V.; Purcell, L.; Yao, C.K.; Landorf, E.; Fitzpatrick, J.A. Practical application of the Crohn's disease exclusion diet as therapy in an adult Australian population. J. Gastroenterol. Hepatol. 2024, 39, 446–456. [Google Scholar] [CrossRef] [PubMed]
- Urlep, D.; Orel, R.; Kunstek, P.; Benedik, E. Treatment of Active Crohn’s Disease in Children Using Partial Enteral Nutrition Combined with a Modified Crohn’s Disease Exclusion Diet: A Pilot Prospective Cohort Trial on Clinical and Endoscopic Outcomes. Nutrients 2023, 15, 4676. [Google Scholar] [CrossRef] [PubMed]
- Alsarhan, A.; Aljasmi, R.; Ajaka, N.; Krishnamurthy, B.; Kader, A.; Aljasmi, M.; Nahdi, N.; Malik, E.Q.; Murbati, B.; Aljabri, E.; et al. Challenges in Managing Paediatric Crohn’s Disease With Crohn’s Disease Exclusion Diet (CDED): The First Single-Center Study in the United Arab Emirates. Cureus 2023, 15. [Google Scholar] [CrossRef] [PubMed]
- Di Caro, S.; Fragkos, K.C.; Keetarut, K.; Koo, H.F.; Sebepos-Rogers, G.; Saravanapavan, H.; Barragry, J.; Rogers, J.; Mehta, S.J.; Rahman, F. Enteral Nutrition in Adult Crohn’s Disease: Toward a Paradigm Shift. Nutrients 2019, 11, 2222. [Google Scholar] [CrossRef] [PubMed]
- Gkikas, K.; Svolos, V.; Hansen, R.; Russell, R.K.; Gerasimidis, K. Take-Home Messages from 20 Years of Progress in Dietary Therapy of Inflammatory Bowel Disease. Ann. Nutr. Metab. 2023, 79, 476–484. [Google Scholar] [CrossRef] [PubMed]

| Question 1. What was your experience with Partial Enteral Nutrition (PEN) in combination with the Crohn’s disease exclusion diet (CDED)? (For example, how did you find it? What do you remember most vividly from the period you followed it? How would you describe this period to someone else? When did you do it? Did you do it once? For how long? What other medication were you taking?) |
| Question 2. For how long did you follow it? |
| Question 3. What are your thoughts on possibly repeating it in a new flare-up period? (For example, would you do the same again? If yes, in what situation? If not, for what reason?) |
| Question 4. What was positive, that is, what did you like about this experience? (For example, what were the advantages? - For example, some people report that it helps with Crohn’s symptoms. - Others mention that they don’t have to worry about what they should eat.) |
| Question 5. What was negative, that is, what did you like about this experience? (For example, what were the disadvantages? - For example, some people report having difficulty when they need to attend a social event. - Cost-Prescription, Cooking, Time, Social eating / eating out, Taste/pleasure) |
| Question 6. What helped you follow it? (For example, how did you decide to follow this plan - Role of the dietitian - Role of the doctor - Role of the family - Who cooked? - Recipes - Motivation - Benefit to symptoms) |
| Question 7. What made it difficult for you to follow it? (For example, social eating - Physical symptoms, e.g., constipation - Support from your environment – Cooking) |
| Question 8. If you were to follow this treatment again, what would you change to make it easier to follow? |
| Question 9. Would you try, in a possible future flare-up, to follow exclusive enteral nutrition (consuming only powdered milk)? |
| Variable | n(%)1 |
| Age (years), median (min-max) | 36.5 (19-53) |
| Gender | |
| Men | 6 (40%) |
| Women | 9 (60%) |
| Diagnosis Duration | |
| >10 years | 5 (33.3%) |
| 6-10 years | 1 (6.7%) |
| 1-5 years | 4 (26.7%) |
| 7-12 months | 5 (33.3%) |
| Previous Hospitalization | |
| Yes | 10 (66.7%) |
| No | 5 (33.3%) |
| Level of education | |
| Postgraduate studies | 2 (13.3%) |
| University / Postsecondary education | 12 (80%) |
| High school / Junior high school | 1 (6.7%) |
| Employment | |
| Part-time Employed | 3 (20%) |
| Full-time Employed | 11 (73.3%) |
| Students | 1 (6.7%) |
| Type of pharmacological treatment2 | |
| Biological agent | 11 (73.3%) |
| Corticosteroids | 3 (20%) |
| Immunosuppressants | 2 (13.3%) |
| Other treatment | 3 (20%) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).